He is making quite an assumption. What evidence does he have to support this assumption ? The studies show glutamate to be a problem early in the injury. Nothing in the article, which is based on 100 other articles, shows that this problem exists for months after the injury. The article explains that much of this problem is due to the mechanisms in place at near injury. These studies are likely based on rat brains since they are the commonly 'experimentally' injured mammals used in brain studies.

Did you ask him about the addiction tendency of phenibut ?

btw, NeuroScience, the maker of Kavinace is also the same company that does the only lab work that determines that a patient needs Kavinace. The research supporting their claims is limited and only done by the NeuroScience and Pharmasan Labs, Inc people Both companies are owned by the same entity/persons.

My best to you.